Endpoint
|
Group
|
Day
|
---|
2
|
6
|
9
|
14
|
---|
Presence of lice
|
NNC
|
38.5%
|
42.3%
|
32.7%
|
23.1%
|
IPM/C
|
41.5%
|
56.6%
|
21.2%
|
18.9%
|
Total lice
|
NNC
|
2.09
|
3.25
|
0.90
|
1.04
|
IPM/C
|
2.34
|
4.11
|
0.42
|
0.42
|
Adult males
|
NNC
|
0.12
|
0.14
|
0.10
|
0.15
|
IPM/C
|
0.15
|
0.06
|
0.01
|
0.04
|
Adult females
|
NNC
|
1.25
|
0.37
|
0.08
|
0.35
|
IPM/C
|
0.26
|
0.15
|
0.00
|
0.19
|
Stage 3 nymphs
|
NNC
|
0.40
|
0.37
|
0.31
|
0.10
|
IPM/C
|
0.40
|
0.30
|
0.09
|
0.09
|
Stage 2 nymphs
|
NNC
|
0.21
|
1.10
|
0.27
|
0.29
|
IPM/C
|
0.47
|
1.21
|
0.13
|
0.09
|
Stage 1 nymphs
|
NNC
|
1.12
|
1.29
|
0.15
|
0.15
|
IPM/C
|
1.06
|
2.40
|
0.19
|
0.02
|
- There were no significant differences between the treatments with regard to numbers of lice found at any assessment day